HC Wainwright reaffirmed their buy rating on shares of Imunon (NASDAQ:IMNN – Free Report) in a research report report published on Thursday morning, Benzinga reports. HC Wainwright currently has a $14.00 price objective on the stock.
Imunon Price Performance
IMNN stock opened at $1.14 on Thursday. Imunon has a 12 month low of $0.48 and a 12 month high of $3.65. The firm’s 50-day moving average is $1.25 and its 200 day moving average is $1.17. The company has a market capitalization of $10.72 million, a PE ratio of -0.56 and a beta of 2.12.
Imunon Company Profile
Featured Articles
- Five stocks we like better than Imunon
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 8/12 – 8/16
- How to Calculate Retirement Income: MarketBeat’s Calculator
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Imunon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imunon and related companies with MarketBeat.com's FREE daily email newsletter.